custom-designed antigen microarray (Thermo Fisher)
Structured Review
Custom Designed Antigen Microarray, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/custom+microarray/custom+designed+antigen+microarray/pm40118130-62-10-13
Average 90 stars, based on 1 article reviews
Images
Related Articles
Binding Assay:Article Title: Divergent and dominant anti-inflammatory effects of patient-derived anticitrullinated protein antibodies (ACPA) in arthritis development Article Snippet: Reactivity against citrullinated peptides and proteins ACPA mAbs were screened for binding to citrullinated, native control peptides and control antigens using a Article Title: Diffuse large B cell lymphoma in rheumatoid arthritis patients is associated with elevated B-cell driving factors including CXCL13. Article Snippet: ACPA fine-specificities to different citrullinated peptides were assessed using a Article Title: Anti-Citrullinated Protein Antibody Reactivity towards Neutrophil-Derived Antigens: Clonal Diversity and Inter-Individual Variation Article Snippet: The bindings of monoclonal ACPA to citrullinated, acetylated and carbamylated peptides were investigated at 5 μg/mL IgG using commercial CCP2 ELISA (CCPlus immunoscan, Svar Life Science, Malmö, Sweden), as well as modified-vimentin peptide ELISA (Mod-Vim 58–69 , Organtec Diagnostics, Mainz, Germany) and a Control:Article Title: Divergent and dominant anti-inflammatory effects of patient-derived anticitrullinated protein antibodies (ACPA) in arthritis development Article Snippet: Reactivity against citrullinated peptides and proteins ACPA mAbs were screened for binding to citrullinated, native control peptides and control antigens using a Article Title: Diffuse large B cell lymphoma in rheumatoid arthritis patients is associated with elevated B-cell driving factors including CXCL13. Article Snippet: ACPA fine-specificities to different citrullinated peptides were assessed using a Article Title: Anti-Citrullinated Protein Antibody Reactivity towards Neutrophil-Derived Antigens: Clonal Diversity and Inter-Individual Variation Article Snippet: The bindings of monoclonal ACPA to citrullinated, acetylated and carbamylated peptides were investigated at 5 μg/mL IgG using commercial CCP2 ELISA (CCPlus immunoscan, Svar Life Science, Malmö, Sweden), as well as modified-vimentin peptide ELISA (Mod-Vim 58–69 , Organtec Diagnostics, Mainz, Germany) and a Microarray:Article Title: Divergent and dominant anti-inflammatory effects of patient-derived anticitrullinated protein antibodies (ACPA) in arthritis development Article Snippet: Reactivity against citrullinated peptides and proteins ACPA mAbs were screened for binding to citrullinated, native control peptides and control antigens using a Article Title: Diffuse large B cell lymphoma in rheumatoid arthritis patients is associated with elevated B-cell driving factors including CXCL13. Article Snippet: ACPA fine-specificities to different citrullinated peptides were assessed using a Article Title: Anti-Citrullinated Protein Antibody Reactivity towards Neutrophil-Derived Antigens: Clonal Diversity and Inter-Individual Variation Article Snippet: The bindings of monoclonal ACPA to citrullinated, acetylated and carbamylated peptides were investigated at 5 μg/mL IgG using commercial CCP2 ELISA (CCPlus immunoscan, Svar Life Science, Malmö, Sweden), as well as modified-vimentin peptide ELISA (Mod-Vim 58–69 , Organtec Diagnostics, Mainz, Germany) and a Enzyme-linked Immunosorbent Assay:Article Title: Divergent and dominant anti-inflammatory effects of patient-derived anticitrullinated protein antibodies (ACPA) in arthritis development Article Snippet: Reactivity against citrullinated peptides and proteins ACPA mAbs were screened for binding to citrullinated, native control peptides and control antigens using a Article Title: Diffuse large B cell lymphoma in rheumatoid arthritis patients is associated with elevated B-cell driving factors including CXCL13. Article Snippet: ACPA fine-specificities to different citrullinated peptides were assessed using a Article Title: Anti-Citrullinated Protein Antibody Reactivity towards Neutrophil-Derived Antigens: Clonal Diversity and Inter-Individual Variation Article Snippet: The bindings of monoclonal ACPA to citrullinated, acetylated and carbamylated peptides were investigated at 5 μg/mL IgG using commercial CCP2 ELISA (CCPlus immunoscan, Svar Life Science, Malmö, Sweden), as well as modified-vimentin peptide ELISA (Mod-Vim 58–69 , Organtec Diagnostics, Mainz, Germany) and a Modification:Article Title: Divergent and dominant anti-inflammatory effects of patient-derived anticitrullinated protein antibodies (ACPA) in arthritis development Article Snippet: Reactivity against citrullinated peptides and proteins ACPA mAbs were screened for binding to citrullinated, native control peptides and control antigens using a Article Title: Diffuse large B cell lymphoma in rheumatoid arthritis patients is associated with elevated B-cell driving factors including CXCL13. Article Snippet: ACPA fine-specificities to different citrullinated peptides were assessed using a Article Title: Anti-Citrullinated Protein Antibody Reactivity towards Neutrophil-Derived Antigens: Clonal Diversity and Inter-Individual Variation Article Snippet: The bindings of monoclonal ACPA to citrullinated, acetylated and carbamylated peptides were investigated at 5 μg/mL IgG using commercial CCP2 ELISA (CCPlus immunoscan, Svar Life Science, Malmö, Sweden), as well as modified-vimentin peptide ELISA (Mod-Vim 58–69 , Organtec Diagnostics, Mainz, Germany) and a Peptide ELISA:Article Title: Divergent and dominant anti-inflammatory effects of patient-derived anticitrullinated protein antibodies (ACPA) in arthritis development Article Snippet: Reactivity against citrullinated peptides and proteins ACPA mAbs were screened for binding to citrullinated, native control peptides and control antigens using a Article Title: Diffuse large B cell lymphoma in rheumatoid arthritis patients is associated with elevated B-cell driving factors including CXCL13. Article Snippet: ACPA fine-specificities to different citrullinated peptides were assessed using a Article Title: Anti-Citrullinated Protein Antibody Reactivity towards Neutrophil-Derived Antigens: Clonal Diversity and Inter-Individual Variation Article Snippet: The bindings of monoclonal ACPA to citrullinated, acetylated and carbamylated peptides were investigated at 5 μg/mL IgG using commercial CCP2 ELISA (CCPlus immunoscan, Svar Life Science, Malmö, Sweden), as well as modified-vimentin peptide ELISA (Mod-Vim 58–69 , Organtec Diagnostics, Mainz, Germany) and a |

